Jared Holz, Mizuho healthcare specialist, joins ‘Squawk on the Street’ to discuss what to expect from Novo Nordisk’s quarterly earnings results, if weight-loss drugs will get covered by insurance, and what’s moved Eli Lilly and Novo Nordisk’s stocks to this point and future growth prospects.
Novo and Eli Lilly stocks could go higher if they show even better data than we think: Mizuho’s Holz
November 11, 2023
